Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$3.82 – $6.51
48% from low
Exchange
OTC Link
ADRC
Borrow rate
3.93%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.13B | $17.88B | $17.14B | $17.67B | $20.63B | $20.42B | $27.33B | $31.82B |
| Cost of revenue | $11.39B | $12.78B | $12.91B | $13.30B | $16.85B | $16.97B | $21.29B | $24.80B |
| Gross profit | $6.74B | $5.11B | $4.23B | $4.36B | $3.78B | $3.45B | $6.04B | $7.02B |
| Gross margin | 37.2% | 28.6% | 24.7% | 24.7% | 18.3% | 16.9% | 22.1% | 22.1% |
| R&D | $1.52B | $1.73B | $1.92B | $1.73B | $1.62B | $1.57B | $2.02B | $1.96B |
| Operating income | $4.26B | $2.47B | $1.34B | $1.48B | $671.7M | $786.7M | $2.29B | $2.81B |
| EBITDA | $6.00B | $4.98B | $3.65B | $4.02B | $4.25B | $4.18B | $5.55B | $5.48B |
| Net income | $3.80B | $2.22B | $1.51B | $1.32B | $821.3M | $740.4M | $1.80B | $2.51B |
| Net margin | 20.9% | 12.4% | 8.8% | 7.5% | 4.0% | 3.6% | 6.6% | 7.9% |
| EPS (diluted) | 3.11 | 1.84 | 1.25 | 1.09 | 0.66 | 0.60 | 1.53 | 2.18 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $36.2B | $2.43 | $2.23–$2.63 | 2 |
| 2027 | $40.5B | $2.81 | $2.63–$2.94 | 2 |
| 2028 | $45.1B | $3.26 | $2.95–$3.75 | 1 |
| 2029 | $52.6B | $3.26 | $2.95–$3.75 | 1 |
Forward consensus · source: Financial Modeling Prep
AAC TECHS HLDGS UNSP/ADR
No one on the platform currently holds AACAY.
No tracked institution reports a position in AACAY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-27 | $0.0447 | 2026-07-02 |
| 2025-05-27 | $0.0306 | 2025-07-03 |
| 2024-05-29 | $0.0128 | 2024-07-05 |
| Execution date | Ratio |
|---|---|
| 2018-02-22 | 10-for-1 |
No one on the platform has traded AACAY yet.
| $4.9B |
| — |
| OMRNFOMRON Corporation | $38.55 | +0.00% | $7.6B | — |
| ROHCYROHM Co., Ltd. | $32.49 | -2.96% | $12.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 3.9× earnings vs its 3.4× historical median P/E.
Fair value ≈ $4.44 · price $5.10 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.